NCT03606668View on ClinicalTrials.gov

Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

March 2, 2020

Study Completion Date

March 2, 2020

Conditions
Multiple SclerosisChronic PainNeurological Disorder
Interventions
DEVICE

HTC Vive Virtual Reality (VR) system

VR treatment will entail use of computer software designed to immerse participants and engage them in exercises. Software includes virtual painting, walking through vivid and calming settings, solving puzzles, among others.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03606668 - Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders | Biotech Hunter | Biotech Hunter